Lumír Hanuš
Lumír Hanuš
Research Fellow , School of Pharmacy, Hebrew University
Verified email at
Cited by
Cited by
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
WA Devane, L Hanuš, A Breuer, RG Pertwee, LA Stevenson, G Griffin, ...
Science 258 (5090), 1946-1949, 1992
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
R Mechoulam, S Ben-Shabat, L Hanus, M Ligumsky, NE Kaminski, ...
Biochemical pharmacology 50 (1), 83-90, 1995
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno, L Hanuš, L De Petrocellis, S Tchilibon, DE Ponde, I Brandi, ...
British journal of pharmacology 134 (4), 845-852, 2001
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
L Hanuš, S Abu-Lafi, E Fride, A Breuer, Z Vogel, DE Shalev, I Kustanovich, ...
Proceedings of the National Academy of Sciences 98 (7), 3662-3665, 2001
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
D Panikashvili, C Simeonidou, S Ben-Shabat, L Hanuš, A Breuer, ...
Nature 413 (6855), 527-531, 2001
Phytocannabinoids: a unified critical inventory
LO Hanuš, SM Meyer, E Muńoz, O Taglialatela-Scafati, G Appendino
Natural product reports 33 (12), 1357-1392, 2016
HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor
L Hanuš, A Breuer, S Tchilibon, S Shiloah, D Goldenberg, M Horowitz, ...
Proceedings of the National Academy of Sciences 96 (25), 14228-14233, 1999
Cannabidiol–recent advances
R Mechoulam, M Peters, E Murillo‐Rodriguez, LO Hanuš
Chemistry & biodiversity 4 (8), 1678-1692, 2007
Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor
L Hanus, A Gopher, S Almog, R Mechoulam
Journal of medicinal chemistry 36 (20), 3032-3034, 1993
Early phytocannabinoid chemistry to endocannabinoids and beyond
R Mechoulam, LO Hanuš, R Pertwee, AC Howlett
Nature Reviews Neuroscience 15 (11), 757-764, 2014
Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects
R Mechoulam, L Hanuš
Chemistry and physics of lipids 121 (1-2), 35-43, 2002
A historical overview of chemical research on cannabinoids
R Mechoulam, L Hanuš
Chemistry and physics of lipids 108 (1-2), 1-13, 2000
Myrrh-commiphora chemistry
LO Hanuš, T Řezanka, VM Dembitsky, A Moussaieff
Biomedical papers 149 (1), 3-28, 2005
Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor
T Sheskin, L Hanuš, J Slager, Z Vogel, R Mechoulam
Journal of medicinal chemistry 40 (5), 659-667, 1997
Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy
I Ujváry, L Hanuš
Cannabis and cannabinoid research 1 (1), 90-101, 2016
Cannabinoids and cytochrome P450 interactions
O Zendulka, G Dovrtelova, K Nosková, M Turjap, A Sulcova, L Hanus, ...
Current drug metabolism 17 (3), 206-226, 2016
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase
MH Rhee, Z Vogel, J Barg, M Bayewitch, R Levy, L Hanuš, A Breuer, ...
Journal of medicinal chemistry 40 (20), 3228-3233, 1997
Overcoming the bell-shaped dose-response of cannabidiol by using cannabis extract enriched in cannabidiol
R Gallily, Z Yekhtin, LO Hanuš
Pharmacology & Pharmacy 6 (2), 75-85, 2015
Pharmacological and therapeutic secrets of plant and brain (endo) cannabinoids
LO Hanuš
Medicinal research reviews 29 (2), 213-271, 2009
Search for endogenous ligands of the cannabinoid receptor
R Mechoulam, L Hanuš, BR Martin
Biochemical pharmacology 48 (8), 1537-1544, 1994
The system can't perform the operation now. Try again later.
Articles 1–20